1. Cowburn AS, Condliffe AM, Farahi N, Summers C, Chilvers ER. Advances in neutrophil biology: clinical implications. Chest 2008; 134: 606-612. PMID:
18779195.
2. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376. PMID:
2536474.
3. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321: 280-287. PMID:
2664516.
4. Beutler B. TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol 2002; 270: 109-120. PMID:
12467247.
5. Nahas N, Molski TF, Fernandez GA, Sha'afi RI. Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. Biochem J 1996; 318: 247-253. PMID:
8761479.
6. Carmody RJ, Chen YH. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol Immunol 2007; 4: 31-41. PMID:
17349209.
7. Su B, Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 1996; 8: 402-411. PMID:
8793994.
8. Renard P, Raes M. The proinflammatory transcription factor NFkappaB: a potential target for novel therapeutical strategies. Cell Biol Toxicol 1999; 15: 341-344. PMID:
10811528.
9. Jonsson-Berling BM, Ohlsson K, Rosengren M. Radioimmunological quantitation of the urinary trypsin inhibitor in normal blood and urine. Biol Chem Hoppe Seyler 1989; 370: 1157-1161. PMID:
2482040.
10. Balduyck M, Davril M, Mizon C, Smyrlaki M, Hayem A, Mizon J. Human urinary proteinase inhibitor: inhibitory properties and interaction with bovine trypsin. Biol Chem Hoppe Seyler 1985; 366: 9-14. PMID:
3847279.
11. Jonsson BM, Loffler C, Ohlsson K. Human granulocyte elastase is inhibited by the urinary trypsin inhibitor. Hoppe Seylers Z Physiol Chem 1982; 363: 1167-1175. PMID:
6923841.
12. Perry JK, Scott GK, Tse CA. Modulation of proliferation of cultured human cells by urinary trypsin inhibitor. Biochim Biophys Acta 1994; 1221: 145-152. PMID:
8148391.
13. Tsujino T, Kawabe T, Omata M. Antiproteases in preventing post-ERCP acute pancreatitis. JOP 2007; 8(4 Suppl): 509-517. PMID:
17625308.
14. Inoue K, Takano H, Shimada A, Yanagisawa R, Sakurai M, Yoshino S, et al. Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol 2005; 67: 673-680. PMID:
15576631.
15. Bae HB, Jeong CW, Li M, Kim HS, Kwak SH. Effects of urinary trypsin inhibitor on lipopolysaccharide-induced acute lung injury in rabbits. Inflammation 2012; 35: 176-182. PMID:
21318392.
16. Nakamura H, Abe S, Shibata Y, Sata M, Kato S, Saito H, et al. Inhibition of neutrophil elastase-induced interleukin-8 gene expression by urinary trypsin inhibitor in human bronchial epithelial cells. Int Arch Allergy Immunol 1997; 112: 157-162. PMID:
9030096.
17. Aosasa S, Ono S, Mochizuki H, Tsujimoto H, Ueno C, Matsumoto A. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. Shock 2001; 15: 101-105. PMID:
11220636.
18. Aibiki M, Cook JA. Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes. Crit Care Med 1997; 25: 430-434. PMID:
9118658.
19. Kwak SH, Mitra S, Bdeir K, Strassheim D, Park JS, Kim JY, et al. The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins. J Leukoc Biol 2005; 78: 937-945. PMID:
16033814.
20. Yum HK, Arcaroli J, Kupfner J, Shenkar R, Penninger JM, Sasaki T, et al. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol 2001; 167: 6601-6608. PMID:
11714830.
21. Arcaroli J, Yang KY, Yum HK, Kupfner J, Pitts TM, Park JS, et al. Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia. J Leukoc Biol 2002; 72: 571-579. PMID:
12223526.
22. Demling RH. Adult respiratory distress syndrome: current concepts. New Horiz 1993; 1: 388-401. PMID:
7922419.
23. Karima R, Matsumoto S, Higashi H, Matsushima K. The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 1999; 5: 123-132. PMID:
10203736.
24. Abraham E, Carmody A, Shenkar R, Arcaroli J. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1137-L1145. PMID:
11076804.
25. Pratt CW, Swaim MW, Pizzo SV. Inflammatory cells degrade inter-alpha inhibitor to liberate urinary proteinase inhibitors. J Leukoc Biol 1989; 45: 1-9. PMID:
2463321.
26. Zaitsu M, Hamasaki Y, Tashiro K, Matsuo M, Ichimaru T, Fujita I, et al. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis 2000; 181: 1101-1109. PMID:
10720537.
27. Selvatici R, Falzarano S, Mollica A, Spisani S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharmacol 2006; 534: 1-11. PMID:
16516193.
28. Molor-Erdene P, Okajima K, Isobe H, Uchiba M, Harada N, Okabe H. Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression. Am J Physiol Heart Circ Physiol 2005; 288: H1265-H1271. PMID:
15539418.
29. Inanami O, Ohta T, Ito S, Kuwabara M. Elevation of intracellular calcium ions is essential for the H2O2-induced activation of SAPK/JNK but not for that of p38 and ERK in Chinese hamster V79 cells. Antioxid Redox Signal 1999; 1: 501-508. PMID:
11233147.
30. Kanayama N, Halim A, Maehara K, Kajiwara Y, Fujie M, Terao T. Kunitz-type trypsin inhibitor prevents LPS-induced increase of cytosolic free Ca2+ in human neutrophils and HUVEC cells. Biochem Biophys Res Commun 1995; 207: 324-330. PMID:
7857284.